BLINCYTO injection

BLINCYTO (Blinatumomab)

  • Medicine Name: Blincyto
  • API: Blinatumomab
  • Dosage Form: Lyophilized powder in a single-dose vial for reconstitution
  • Strength: 35 mcg
  • Manufacturer Name: Amgen Inc.
Get Price
Category: Tags: , , , , ,

Description

Blincyto (blinatumomab) is a bispecific CD19-directed CD3 T-cell engager indicated for the treatment of adult and pediatric patients with:

  • CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%. Relapsed or refractory CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL).

  • Posology & Administration: The recommended dosage of Blincyto (blinatumomab injection) is administered as a continuous IV infusion for 28 consecutive days per cycle involving a 24/7 infusion followed by 14 days off from infusion. The dose mainly depends on a patient’s actual body weight. Patients weighing over 45 kg should receive fixed doses while patients weighing less than 45 kg should receive doses depending on their estimated body surface area.

Important Safety Information

Cytokine Release Syndrome (CRS): Blincyto 35 mcg can cause CRS, a systemic inflammatory response syndrome characterized by fever, chills, hypotension, and other symptoms. Patients should be closely monitored for signs and symptoms of CRS, and appropriate supportive care should be provided as needed.

Neurologic Toxicities: Neurologic toxicities, including seizures, encephalopathy, and other adverse events affecting the central nervous system, can occur with this treatment. Patients should be monitored for neurologic symptoms, and treatment should be interrupted or discontinued if neurotoxicity is suspected.

Infections: This therapeutic drug may increase the risk of infections, including bacterial, fungal, and viral infections.

Patients should be monitored for signs and symptoms of infection, and appropriate antimicrobial therapy should be initiated as needed.

Tumor Lysis Syndrome (TLS): TLS, characterized by metabolic abnormalities such as hyperuricemia, hyperkalemia, hypocalcemia, and hyperphosphatemia, can occur with blinatumomab 35 mcg treatment. Patients with high tumor burden or rapidly proliferating tumors are at increased risk. Hydration and close monitoring of electrolytes are recommended to prevent TLS.

Hypersensitivity Reactions: Hypersensitivity reactions, including anaphylaxis, can occur with Blincyto administration. Patients should be monitored for signs of hypersensitivity, and treatment should be discontinued if a reaction occurs.

Embryo-Fetal Toxicity: Blinatumomab treatment can cause fetal harm when administered to pregnant women. Pregnancy should be avoided during treatment, and effective contraception should be used by both males and females of reproductive potential.

Documentation & Availability

What documents are required to import BLINCYTO to India? BLINCYTO (Blinatumomab) Injections can be imported by patients or government hospitals on the name of the patients only. The following documentation is needed to import the product:
  • A valid prescription from a qualified doctor.
  • Patients diagnostic reports
  • Patient ID proof (issued by the government of India)
How does the order be confirmed? The order will be confirmed only after the receipt of:
  • Valid prescription of Doctor
  • Import permit if applicable
Is BLINCYTO available in India? BLINCYTO (Blinatumomab Injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed. IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
  • On availability of Blincyto in India ( Kolkata, Hyderabad, Mumbai, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  • Medicine Price.
  • Finding Authentic and reliable sources from USA, Canada, Europe, and Australia
  • Ensuring 100% transparency.
BLINCYTO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit. TIP (The Indian Pharma) can facilitate the supply of BLINCYTO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable). Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@theindianpharma.com for the Blincyto injection price in India. We guarantee quality and delivery in every corner of the world as per the buyer’s requirements.

Sourcing & Delivery

The Indian Pharma (TIP) can source BLINCYTO (Cancer Treatment Medicines) from across the globe and can supply. TIP offers its customers worldwide access to the best available treatment.

The Indian Pharma (TIP) has the potential to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

 

FAQs

What does Blincyto contain as an active substance?

Blincyto contains the active substance Blinatumomab.

How is Blincyto supplied?

Blincyto is supplied as injections: 35 mcg of lyophilized powder in a single-dose vial for reconstitution. It is available by prescription only.

What are the common side effects of Blincyto?

Common side effects of Blincyto may include infusion-related reactions, pyrexia, infections (pathogen unspecified), headache, anemia, neutropenia, and thrombocytopenia.

How much does Blincyto cost in India?

Get the best cost of Blincyto in India. If you want to buy it online, then THE INDIAN PHARMA (TIP) can help you access this medicinal product at the most competitive price in India through legal channels.

How to store Blincyto?

Store Blincyto and IV Solution Stabilizer vials in the original package refrigerated at 2 to 8°C (36 to 46°F) and protect them from light until the time of use. Do not freeze.

Is the Blincyto Injection Available In India?

Blincyto is an imported medicine that is not readily available in India. It can be imported against a valid prescription and import permit. THE INDIAN PHARMA (TIP) can facilitate the supply of Blincyto Injections after fulfilling the legal requirement (if applicable). Please contact us via +919310090915 or TOLL-FREE: 1800-889-1064 or write to us at info@theindianpharma.com to buy Blincyto online in India.

Can I get Blincyto even if I am not based in India?

THE INDIAN PHARMA (TIP) helps patients access/import Blincyto (Blinatumomab), not approved in their home country against the valid prescription and in conformity with local laws and regulations of their respective country.

Where can I get Blincyto at the best price?

To get the best Blincyto price in India and other countries, always buy this medicinal product from a Pharmaceutical Wholesaler Company that is GDP-certified. Noida-based THE INDIAN PHARMA (TIP) can offer the best price for Blincyto (Blinatumomab).

Is it safe to buy Blincyto online in India?

Yes, one can buy Blincyto Injections online from India-based The Indian Pharma (TIP) if this therapeutic drug is not registered or is unavailable in the country. We can facilitate the supply of Blincyto Injections through legal channels.

Related products

×